Cellarity
AI and multi-omics drug discovery of oral medicines that correct dysfunctional cell states in complex diseases
Highlights
- New on EvolcAdded 2026-11-14
About Cellarity
Cellarity is a drug discovery company that develops oral "cell state-correcting" therapeutics for complex diseases. Its multi-omics and AI-powered platform maps cell and gene interactions at single-cell resolution and predicts chemical interventions that restore healthy cell function. The company states that its first cell state-correcting candidate is entering clinical studies.
The platform combines high-dimensional transcriptomics, single-cell foundation models, human in-vitro modelling and a chemistry engine that designs novel, orally available compounds. Its leadership and board combine experience in drug development, machine learning, computational biology and chemistry, with prior roles at pharma and biotech companies.
Cellarity was launched by Flagship Pioneering in 2019. It has an open role for a Director, Pharmacology in Preclinical Development & Translational Research in Somerville, Massachusetts.
Product: Oral small-molecule therapeutics designed with an AI-driven, multi-omics discovery platform that targets dynamic disease cell states.
Jobs at Cellarity
Open roles at Cellarity in the Americas (1)
United States 1. From Cellarity's careers page or applicant tracking system; each role links to the employer.
- Director, Pharmacology · Somerville, United States
More biotech & pharma companies
Cellular Intelligence
Develops AI and biology approaches to engineer cell fate for biomedical and drug-development applicationsNew on EvolcCentrillion Technologies
High-density DNA chips and molecular measurement platforms for life science researchers and diagnostic partnersNew on EvolcChai Discovery
AI-based molecular design tools for pharmaceutical and life sciences companies developing medicinesNew on EvolcClimb Bio
Develops monoclonal antibody medicines for people with immune-mediated diseasesNew on EvolcCoderabio
Drug development expertise and infrastructure for biotechnology and pharmaceutical companiesNew on EvolcCogent Biosciences
Develops precision therapies for patients with genetically defined diseases, including cancers and rare diseasesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- GreenhouseMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
